Dapagliflozin
10 mg · Tablet
- Prescription only
- Sodium-Glucose Cotransporter 2 Inhibitor
- Active substance
- Dapagliflozin
- Made by
- Zydus Lifesciences Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (DAPAGLIFLOZIN). It describes the substance, not this exact product.
Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen.
Dapagliflozin is an inhibitor of SGLT2.
The metabolism of dapagliflozin is primarily mediated by UGT1A9; CYP-mediated metabolism is a minor clearance pathway in humans.
Dapagliflozin and related metabolites are primarily eliminated via the renal pathway.
Administration of dapagliflozin with a high-fat meal decreases its C max by up to 50% and prolongs T max by approximately 1 hour but does not alter AUC as compared with the fasted state.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-08
Safety of the active substance
From the US prescribing label for the same active substance (DAPAGLIFLOZIN). It describes the substance, not this exact product.
- Dapagliflozin is contraindicated in patients with a history of a serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin.
- Serious hypersensitivity reactions, including anaphylaxis and angioedema have been reported with dapagliflozin [see Adverse Reactions ( 6.1 )].
- History of serious hypersensitivity reaction to dapagliflozin or any of the excipients in dapagliflozin.
The most frequently reported genital mycotic infections were vulvovaginal mycotic infections in females and balanitis in males.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria11 matching products
- Dagrafors 10 mg · film-coated tablets2 makers
- Dapagliflozin Polpharma 10 mg film-coated tablets (calendar blister) · film-coated tablets2 makers
- Dagetia Dagetia 10 mg · film-coated tablets
- Dalzior Casseo 10 mg · film-coated tablets
- Dapagliflozin Sandoz 10 mg · film-coated tablets
- Dapagliflozin Tchaikapharma 10 mg · film-coated tablets
- Dapalif 10 mg · film-coated tablets
- Dapastada 10 mg · film - coated tablets
European UnionNo exact match for this strength and form
Details
| Made by | Zydus Lifesciences Limited |
|---|---|
| Active substance | Dapagliflozin |
| Strength | 10 mg |
| Form | Tablet |
| Route | Oral |
| Packs | 30 TABLET in 1 BOTTLE · 90 TABLET in 1 BOTTLE |
| NDC | 70771-1715 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
41 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Film Coated29 products
- Tablet12 products
10 mg6
10 mg · 6 companies
- Ajanta Pharma USA Inc.
- Florida Pharmaceutical Products, LLC
- Lupin Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Limited
- Zydus Lifesciences Limited · this page
- Zydus Pharmaceuticals USA Inc.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.